(RGLS) Regulus Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Regulus Therapeutics | (RGLS) share price targets
Complete technical analysis of Regulus Therapeutics (RGLS) by charts plus indicators, forecast predictions and share price targets for Regulus Therapeutics (RGLS)
Regulus Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-25 View latest technical analysis
10 day averaged volume of Regulus Therapeutics is 1961190
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 2.14 | 2.05 | 2.30 | 2.01 | 1 times |
| 24 Mon Jun 2024 | 2.05 | 2.05 | 2.40 | 1.95 | 5.598 times |
| 21 Fri Jun 2024 | 2.51 | 2.57 | 2.59 | 2.37 | 2.145 times |
| 20 Thu Jun 2024 | 2.52 | 2.45 | 2.55 | 2.37 | 0.479 times |
| 18 Tue Jun 2024 | 2.48 | 2.38 | 2.50 | 2.32 | 0.439 times |
| 18 Tue Jun 2024 | 2.48 | 2.38 | 2.50 | 2.32 | 0.439 times |
| 17 Mon Jun 2024 | 2.37 | 2.42 | 2.51 | 2.32 | 0.175 times |
| 14 Fri Jun 2024 | 2.41 | 2.45 | 2.51 | 2.41 | 0.12 times |
| 13 Thu Jun 2024 | 2.48 | 2.37 | 2.56 | 2.35 | 0.169 times |
| 12 Wed Jun 2024 | 2.37 | 2.42 | 2.51 | 2.33 | 0.217 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.2, but if it comes above 2.2, then a intra day buy could be more profitable.
If you take a sell trade below 2.2, then use 2.2 as stoploss and 2 as target. However if you take a buy trade in stock , then use 2.2 as stoploss and 2.33 as target.
Share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Target | 1.25 |
| Downside Target | 1.32 |
| Downside Target | 1.74 |
| Downside Target | 1.79 |
| Downside Target | 1.95 |
| Downside Target | 2.09 |
| Downside Target | 2.14 |
| Upside Target | 2.23 |
| Upside Target | 2.32 |
| Upside Target | 2.40 |
| Upside Target | 2.50 |
| Upside Target | 2.59 |
| Upside Target | 2.90 |
| Upside Target | 2.91 |
| Upside Target | 3.79 |
Intraday share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Intraday Target | 1.93 |
| Downside Intraday Target | 1.71 |
| Upside Intraday Target | 2.38 |
| Upside Intraday Target | 2.61 |
| Upside Intraday Target | 2.16 |
Weekly technical analysis of Regulus Therapeutics (RGLS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 2.14 | 2.05 | 2.40 | 1.95 | 2.155 times |
| 21 Fri Jun 2024 | 2.51 | 2.38 | 2.59 | 2.32 | 4.992 times |
| 18 Tue Jun 2024 | 2.48 | 2.42 | 2.51 | 2.32 | 0.55 times |
| 14 Fri Jun 2024 | 2.41 | 2.23 | 2.56 | 2.23 | 1.364 times |
| 07 Fri Jun 2024 | 2.23 | 2.34 | 2.50 | 2.14 | 0.668 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Regulus Therapeutics (RGLS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 2.14 | 2.34 | 2.59 | 1.95 | 2.093 times |
| 31 Fri May 2024 | 2.29 | 2.30 | 2.90 | 1.79 | 1.719 times |
| 30 Tue Apr 2024 | 2.30 | 2.90 | 2.91 | 2.09 | 0.036 times |
| 28 Thu Mar 2024 | 2.88 | 1.48 | 3.79 | 1.32 | 164.297 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Regulus Therapeutics (RGLS)
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term but the sell signal is initial and weak.
Regulus Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Regulus Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Regulus Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.23 and Regulus Therapeutics (RGLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term but the sell signal is initial and weak.
Regulus Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Regulus Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Regulus Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.23 and Regulus Therapeutics (RGLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.